Name | Value |
---|---|
Revenues | 47.8M |
Cost of Revenue | 425.1M |
Gross Profit | -377.2M |
Operating Expense | 1,984.1M |
Operating I/L | -2,361.3M |
Other Income/Expense | -1,043.0M |
Interest Income | 0.0M |
Pretax | -3,404.3M |
Income Tax Expense | 0.0M |
Net Income/Loss | -3,404.3M |
AquaBounty Technologies, Inc. is a biotechnology company specializing in enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company conducts genetic, genomic, and fish health and nutrition research to develop and market its products. Its primary offering is the AquAdvantage Salmon, a bioengineered Atlantic salmon designed for human consumption. Additionally, AquaBounty Technologies, Inc. sells conventional Atlantic salmon, salmon eggs, fry, and byproducts, generating revenue through the sale of these aquaculture products.